Malvern Panalytical

Malvern Panalytical

Analytical instruments for materials characterization

Overview

Malvern Panalytical sells analytical instruments and materials-characterization tools used to study the chemical, physical, and structural properties of materials. Its instruments work by analyzing samples with techniques such as particle sizing, zeta potential, diffraction for crystal structure, and adsorption tests for surface area and porosity. The company differentiates itself with a broad, integrated product portfolio, deep technical expertise, and a large global installed base with strong service and support. Its goal is to help customers discover and optimize materials while pursuing sustainability goals, including net-zero operations by 2030 and net-zero across the value chain by 2040 as part of Spectris.

About Malvern Panalytical

Simplify's Rating
Why Malvern Panalytical is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Industrial & Manufacturing

Energy

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Almelo, Netherlands

Founded

1971

Get referred to Malvern Panalytical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • KKR completed Spectris acquisition in December 2025, backing faster investment decisions.
  • Malvern launched Revontium and Mastersizer 3000+, expanding cross-sell into mining and labs.
  • Battery and sustainability demand strengthened after Future Days 2025 and 2026 customer messaging.

What critics are saying

  • Spectris said Almelo ERP issues shifted £15 million sales and £10 million profit into H2.
  • Micromeritics integration risks channel conflict and missed synergies before 2026 closes.
  • Waters patent litigation keeps draining management attention and can block specific instrument sales.

What makes Malvern Panalytical unique

  • Malvern spans particle sizing, XRF, diffraction, and bioanalysis across pharma, batteries, materials.
  • Creoptix added GCI drug-discovery kinetics; Micromeritics expands porous-materials characterization.
  • Future Days 2025 showcased integrated battery workflow from cathode manufacturing to recycling.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Unlimited Paid Time Off

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Gym Membership

Mentorship Program

Professional Development Budget

Conference Attendance Budget

Training Programs

Stock Options

Company Equity

Pension Scheme

Family Planning Benefits

Fertility Treatment Support

Parental Leave

Adoption Assistance

Childcare Support

Student Loan Assistance

Relocation Assistance

Employee Discounts

Company Social Events

Company News

Malvern Panalytical
Mar 27th, 2026
Our UK Pharmaceutical Conference is coming to Birmingham - Register now.

Our UK Pharmaceutical Conference is coming to Birmingham - Register now. by Annalisa Soldani, Friday, 27th March 2026 On 3 June, Malvern Panalytical's UK Pharmaceutical Conference returns to Birmingham for its fourth year, bringing together pharmaceutical scientists focused on small molecule development, solid-state chemistry, formulation, and analytical science. Wednesday 3 June 2026 | Edgbaston Park Hotel & Conference Centre, Birmingham, UK If your work involves understanding materials, controlling solid forms, or reducing development risk, this is a great opportunity to engage directly with experts and peers facing the same challenges. With attendance limited to around 50 delegates, this is a focused, high-value event built for meaningful discussion, practical insight, and direct access to experts. Places are limited, so early registration is strongly recommended. Why you should join us. Small molecule development continues to demand more from scientific teams: shorter timelines, tighter control, better data, and greater confidence at every stage. Scientists today are under pressure to: * accelerate development without increasing risk * control solid forms and polymorphism more effectively * avoid scale-up issues that can disrupt progress * generate analytical insight that supports better decisions earlier Our agenda is designed to help you navigate these challenges. Across the day, you will hear practical case studies, expert perspectives, and application-focused talks that address the challenges development teams are dealing with right now. We won't be talking theory, but real science, real workflows, and real strategies that support better outcomes. See analytical technologies in action. Live demonstrations from Malvern Panalytical and Micromeritics will show how powerful analytical data can support decision-making across development and quality workflows. Small format, big impact. Large events can be busy, broad, and easy to get lost in. With around 50 attendees, you will have more opportunities to ask questions, join discussions, and speak directly with specialists, speakers, and peers facing similar challenges. The smaller format creates space for deeper conversations and stronger connections. This year, the event will also include poster presentations, opening up even more opportunities to exchange ideas, showcase work, and start valuable conversations with an engaged audience. Meet the speakers. We're proud to welcome a strong lineup of speakers, including: * Dr Jonathan Loughrey, Director of Chemical Development, Almac Group * Dr Yvonne Perrie (MBE), Professor in Drug Delivery, University of Strathclyde * Dr Steve Ward-Smith, Senior Technical Specialist, Malvern Panalytical * Dr Natalia Dadivanyan, Market Development Manager - Small Molecule Pharmaceuticals, Malvern Panalytical More speakers and the full agenda will be announced soon. Join us in Birmingham. Malvern Panalytical's 4th Annual UK Pharmaceutical Conference will take place on: | Wednesday 3 June 2026 | Edgbaston Park Hotel & Conference Centre, Birmingham, UK Spaces are limited so early registration is highly recommended. Register now to reserve your seat: https://events.malvernpanalytical.com/E2026-uk-pharma-conference Book your place today.

AZoM
Jun 9th, 2025
Malvern Panalytical's Future Days 2025 Illuminates the Path Forward for Battery Innovation and Sustainability

On May 21, 2025, Malvern Panalytical hosted its annual Future Days event, spotlighting the transformative trends in battery technology and recycling.

StartupTicker
Jun 2nd, 2025
Creoptix joins the Malvern Panalytical team in England

The acquisition of Creoptix AG, a specialist bioanalysis sensor company, enables Malvern Panalytical to expand its capabilities in support of drug discovery. The latter provides advanced analysis and services solutions for the pharma drug product development, as well as services and solutions for other industries.

Malvern Panalytical
Jul 22nd, 2024
Say hello to the new Malvern Panalytical MyStore

Malvern Panalytical Inc. has launched the new MyStore with a fresh new look, making it faster to quote and order Malvern Panalytical parts, consumables, accessories, and software.

MarketScreener
Jul 16th, 2024
Spectris to buy Micromeritics for $630M

Spectris Plc will acquire Georgia-based Micromeritics Instrument Corp for $630 million, with an additional deferred consideration of up to $53 million. The acquisition will expand Spectris' laboratory analytical instruments unit. Terry Kelly, CEO of Micromeritics, will become president of Spectris' Malvern Panalytical unit. Spectris expects the deal to be accretive to earnings per share in the first year post-completion.

Recently Posted Jobs

Sign up to get curated job recommendations

Malvern Panalytical is Hiring for 9 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →